True North Advisors LLC Buys New Position in Mettler-Toledo International, Inc. $MTD

True North Advisors LLC bought a new stake in Mettler-Toledo International, Inc. (NYSE:MTD) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 491 shares of the medical instruments supplier’s stock, valued at approximately $619,000.

Other institutional investors also recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. grew its stake in shares of Mettler-Toledo International by 83.3% in the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after acquiring an additional 30 shares during the last quarter. Baird Financial Group Inc. raised its stake in Mettler-Toledo International by 3.1% during the 2nd quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock valued at $1,582,000 after purchasing an additional 40 shares during the last quarter. Jump Financial LLC boosted its holdings in Mettler-Toledo International by 44.6% in the 2nd quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock valued at $476,000 after purchasing an additional 125 shares during the period. Cerity Partners LLC boosted its holdings in Mettler-Toledo International by 10.8% in the 2nd quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock valued at $4,740,000 after purchasing an additional 392 shares during the period. Finally, AXA S.A. grew its position in Mettler-Toledo International by 2.9% in the 2nd quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock worth $5,433,000 after purchasing an additional 131 shares during the last quarter. 95.07% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Wolfe Research assumed coverage on shares of Mettler-Toledo International in a report on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Morgan Stanley decreased their target price on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 12th. Stifel Nicolaus lowered their price target on Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating on the stock in a research note on Monday, May 18th. JPMorgan Chase & Co. cut their price target on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating for the company in a report on Monday, May 11th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Mettler-Toledo International in a research report on Tuesday, July 7th. Six investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and an average target price of $1,408.55.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock opened at $1,310.09 on Monday. The company has a market capitalization of $26.48 billion, a PE ratio of 30.72, a price-to-earnings-growth ratio of 2.74 and a beta of 1.24. The business has a 50 day simple moving average of $1,182.01 and a 200 day simple moving average of $1,281.77. Mettler-Toledo International, Inc. has a one year low of $1,023.05 and a one year high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share for the quarter, topping the consensus estimate of $8.70 by $0.21. The business had revenue of $947.13 million for the quarter, compared to analyst estimates of $943.14 million. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The firm’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. Equities analysts anticipate that Mettler-Toledo International, Inc. will post 46.63 earnings per share for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.